A possible interaction of thyrostatic drugs with myeloperoxidase may therefore also lead to the formation of reactive metabolites in neutrophils and thus to the formation of modified proteins that act as antigens and contribute to the initiation of agranulocytosis. Here, MPO is linked to Absence of circulating granulocytes.